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Amphiphilic polymers containing weakly ionisable carboxyl groups and hydrophobic alkyl 
side chains can mimic the cell transduction function of viral peptides.[1] Such polymers 
display a change of conformation from extended chains to collapsed, hydrophobically-
stabilized globular structures in response to acidification below their pKa ranges.[2] This 
change leads to increased binding of polymers to eukaryotic cell membranes and subsequent 
membrane disruption.[3–5] The pH-mediated conformational change depends principally on the 
balance between the hydrophobic interaction associated with hydrophobic moieties and the 
electrostatic repulsion resulting from charged carboxyl groups.[6] The hydrophobicity of 
pendant hydrophobic groups is one of the factors that influence the conformational behaviour 
of pH-responsive polymers.[3,6,7] Thus, the vinyl polymers poly(α-methylacrylic acid), poly(α-
ethylacrylic acid) and poly(α-propylacrylic acid) undergo conformational change at 
progressively higher pH values, corresponding to increasing endosomal membrane lysis 
activity.[8–12]  
Eccleston et al. [13–15] described a biodegradable, metabolite-derived polyamide, 
poly(L-lysine iso-phthalamide) with a hydrophobic backbone and pendant carboxyl groups. 
Despite lacking hydrophobic side chains presented in fusogenic peptides and poly(α-
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alkylacrylic acid)s, poly(L-lysine iso-phthalamide) displays a pH-dependent conformational 
change [16–18] and weak cell membrane lytic capacity over a low pH range (pH 4.6 –   
5.0).[19,20] Recently pH-responsive polymers have been synthesized by grafting hydrophobic 
amino acids, L-valine, L-leucine and L-phenylalanine, onto the carboxylic acid moieties along 
the backbone of poly(L-lysine iso-phthalamide). The effects of hydrophobicity and structure 
of grafted side chains and degree of grafting on the pH-responsiveness of polymer 
conformation and aggregation, cell membrane-disruptive activity, in-vitro cytotoxicity and 
intracellular trafficking of the grafted polymers have been demonstrated and presented 
elsewhere.[21–23] Of these derivatives, the polymer with the optimal properties for endosomal 
membrane disruption is the phenylalanine derivatized polymer PP-75 at a stoichiometric 
degree of substitution of 75 mol% (M  = 24.9 kDa, degree of grafting = 63.2%).n [21,22] In sheep 
erythrocyte models of endosomes, PP-75 was 35-fold more membrane-disruptive on a molar 
basis than the highly lytic bee-sting peptide melittin at pH 6.5, within the pH range 
characteristic of early endosomes. PP-75 was not cytotoxic towards mammalian cells up to a 
polymer concentration of 2 mg mL-1 after 2 hours of treatment. After 48 hours, PP-75 almost 
had no cytotoxic effects at the concentration < 0.125 mg mL-1, whilst progressively decreased 
cell viability to 28% with increasing concentration up to 2 mg mL-1.[22]  
Based on previous successful intracellular delivery of the model drug calcein,[22] it was 
thought that PP-75 may be able to deliver biological molecules (proteins and nucleic acids) 
through endosomal release. This study examines the ability of the synthetic polymer PP-75 to 
deliver Apoptin protein into mammalian cells. Apoptin, derived from Chicken Anemia Virus 
(CAV), has a relative molecular mass of 13.6 kDa. Apoptin has been shown to induce 
apoptosis in more than 70 different tumour cell lines, while leaving normal cells (i.e. primary 
fibroblasts, keratinocytes, smooth muscle cells, T cells, endothelial cells) unharmed. Though 
the exact mechanism(s) are still under investigation, two key processes (i.e. tumour-specific 
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phosphorylation and tumour-specific nuclear localization) are thought to play major roles in 
its unique activity.[24]  Furthermore, Apoptin-mediated apoptosis is induced in a p53 and Bcl-
2 independent manner,[25] making it a highly attractive therapeutic strategy for aggressive 
cancers. Exploitation of that strategy is, however, currently hampered by the lack of a 
clinically acceptable means of transporting Apoptin into cells. Currently, all studies of 
Apoptin delivery have been based on gene delivery or microinjection.[24] This paper 
demonstrates the ability of PP-75 to mediate the transport of Apoptin into human osteogenic 
sarcoma Saos-2 cells. Here, Apoptin was used in the form of a fusion protein with maltose 
binding protein (MBP). MBP is routinely used to solubilize recombinant proteins with a 
proclivity for aggregation. In this case, the resulting MBP-Apoptin (MA, 55.8 kDa) is easily 
purified from bacterial cell extracts whereas Apoptin alone forms insoluble inclusion bodies 
following translation in E. coli. Noteborn and colleagues demonstrated that this recombinant 
protein exhibits biological activity nearly identical to ectopically expressed Apoptin.[26] In all 
studies, MBP-Apoptin was used at a final concentration of 33 μg mL-1 (0.6 μM). 
First, the uptake of FITC labeled PP-75 (PP-75-FITC) into Saos-2 cells was studied. 
The Saos-2 cell line (ATCC HTB85) is derived from an osteogenic sarcoma from an 11 year 
old Caucasian female that underwent chemotherapy.[27] The cell line is p53 negative and 
serves as a model for tumours with missing or mutated p53. Flow cytometry experiments 
were conducted to quantify the polymer uptake after one hour incubation with PP-75-FITC. 
As expected, both the proportion of cells with internalized PP-75-FITC and amount of 
internalized PP-75-FITC increased with polymer concentration (data not shown). The 
proportion of viable Saos-2 cells with internalized PP-75-FITC increased from approximately 
50% FITC+ at 12.5 μg mL-1 PP-75-FITC to nearly 80% FITC+ at 100 μg mL-1 PP-75-FITC. 
A similar trend was observed for mean fluorescence, which increased in a nearly linear 
fashion from 12.5 to 50 μg mL-1 polymer. From 50 to 100 μg mL-1 polymer there was little 
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increase in the mean fluorescence. These flow cytometry data were corroborated by visual 
evidence from confocal microscopy. Control cells incubated in culture medium only exhibited 
no fluorescence. Cells treated with 25 μg mL-1 PP-75-FITC for 1 hour displayed a relatively 
low level of fluorescence whereas cells treated with 50 and 100 μg mL-1 PP-75-FITC 
displayed a substantial increase in fluorescence. 
 The concentration-dependence of MBP-Apoptin•PP-75 interaction has been 
investigated (Fig. 1). Native polyacrylamide gel electrophoresis (PAGE) assays were 
performed to examine if the addition of PP-75 retarded the movement of MBP-Apoptin under 
native electrophoresis conditions. As seen from the polymer-only lanes in Fig. 1A, high 
concentrations (e.g. 700 – 1000 μg mL-1) resulted in a large polymer structure that ran near 
150 – 75 kDa, indicating concentration-dependent hydrophobic association of the polymer. 
The broad staining in these lanes may be due to the formation of variable-sized hydrophobic 
aggregates.[21] 
 In-vitro, MBP-Apoptin spontaneously forms soluble, non-covalent, globular 
complexes approximately 80 nm in diameter.[28] Attributed to the N-terminal portion of 
Apoptin and stabilized by hydrophobic interactions, these complexes are composed of 30 – 40 
MBP-Apoptin subunits [28] and have estimated molecular weight of approximately 2.5 ± 0.3 
MDa.[29] This multimerization of MBP-Apoptin accounts for its minimal migration in the 
leftmost lane of Fig. 1A. Interestingly, the concentration of PP-75 in Fig. 1A was sufficient to 
dissociate the multimeric MBP-Apoptin complex and resulted in a sharp band near 48 kDa 
(long arrow). MBP-Apoptin runs at 55.8 kDa band under denaturing conditions,[29] so 48 kDa 
is within the error (~15%) of using Native PAGE for molecular weight estimation. Complex 
dissociation is likely due to intercalation and solubilization of multimeric MBP-Apoptin 
globules by PP-75, enabling the migration of individual MBP-Apoptin subunits through the 
gel. The three faint bands surrounding MBP-Apoptin can be ascribed to three expression 
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products (short arrows) consistently co-purified with MBP-Apoptin.[29] Based on the broad 
staining pattern near the top of the gel, PP-75 was unable to completely dissociate the MBP-
Apoptin complex. 
 In Fig. 1B, PP-75 concentration was not sufficient to dissociate the multimeric MBP-
Apoptin complexes. The presence of 100 μg mL-1 PP-75 resulted in wider staining pattern 
than MBP-Apoptin alone but did not induce significant change in the protein migration. The 
effect is similar, though less pronounced, as polymer concentration decreases. This indicates 
inefficient and incomplete dissociation of MBP-Apoptin complexes at lower PP-75 
concentrations. The critical concentration at which PP-75 can dissociate MBP-Apoptin 
complexes has yet to be confirmed, but preliminary experiments indicate this is near 400 – 
600 μg mL-1 PP-75 for 33 μg mL-1 MBP-Apoptin. 
 Flow cytometry experiments were conducted to examine the ability of PP-75 to 
facilitate delivery of fluorescent MBP-Apoptin conjugated with Alexa Fluor 647 (MA-AF647) 
to Saos-2 cells (Fig. 2). As shown in Fig. 2A, a majority of Saos-2 cells were able to 
internalize the fluorescent protein, irrespective of PP-75-FITC concentration. In cells treated 
with 0.6 μM naked MA-AF647, nearly 90% exhibited protein uptake. The amount increased 
slightly to approximately 98% upon the addition of PP-75-FITC, even at a dilute 
concentration of 5 μg mL-1. The mean fluorescence MA-AF647 in viable cells, shown in Fig. 
2B, demonstrates that low concentrations of PP-75-FITC are able to enhance the uptake of 
constitutively internalized MA-AF647 although low concentrations of the polymer (≤100 μg 
mL-1) were found insufficient to dissociate the multimeric MBP-apoptin complexes (Fig. 1B). 
The presence of 5 μg mL-1 PP-75-FITC resulted in mean fluorescence two fold greater than 
naked MA-AF647. This amount increased further in the presence of 10 μg mL-1 PP-75-FITC. 
 The effect of increasing polymer concentration to moderate (25 and 100 μg mL-1) and 
high (500 and 1000 μg mL-1) levels on MA-AF647 delivery was also investigated. Again, 
 5 
   Submitted to  
MA-AF647 was internalized in nearly all viable cells as shown in Fig. 2C. In samples treated 
with 0.6 μM naked MA-AF647, nearly 85% of cells demonstrated MA-AF647 uptake. 
Presence of PP-75-FITC increased this value to near 100%. Despite uptake by a large 
proportion of Saos-2 cells (Fig. 2C), naked MA-AF647 does not accumulate in cells to an 
appreciable extent, as shown by the minimal increase in fluorescence relative to control in Fig. 
2D. However, incorporation with the polymer resulted in a significant increase in the amount 
of internalized MA-AF647 as the mean fluorescence of cells treated with 25 μg mL-1 PP-75-
FITC and 33 μg mL-1 MA-AF647 increased nearly 8-fold relative to naked MA-AF647. 
Similarly, samples treated with 100 μg mL-1 PP-75 demonstrated a 7-fold increase in mean 
fluorescence of MA-AF647 relative to naked MA-AF647. Further increase in polymer 
concentration to 500 and 1000 μg mL-1 PP-75 resulted in a decreased ability to deliver MA-
AF647 and the level of protein fluorescence in samples treated with 1000 μg mL-1 PP-75-
FITC was comparable to that of naked MA-AF647. This may possibly arise from dissociation 
of multimeric MBP-Apoptin complexes observed only at high polymer concentrations (Fig 
1A) and suggests an optimum protein:polymer ratio for efficient protein transduction. 
 These flow cytometry data were validated by the studying the intracellular distribution 
and co-localization of MA-AF647 and PP-75-FITC using confocal microscopy. Fig. 3 
displays evidence that PP-75 both enhances uptake and facilitates cytoplasmic release of MA-
AF647. The image in Fig. 3A shows cells treated with 100 μg mL-1 PP-75-FITC alone. The 
diffuse staining pattern in the FITC channel is indicative of efficient release into the 
cytoplasm.[22,30] The overlay image verifies that the diffuse staining is present within the cell 
membrane. Samples treated with MA-AF647 alone displayed evidence of the constitutive, 
low-level uptake of naked protein observed in flow cytometry experiments. Cells contained 
faint spots in the MA-AF647 channel (data not shown). The punctuate staining pattern 
suggests that naked MA-AF647 remains trapped in vesicular compartments.[22,30] Viable cells 
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incubated with unconjugated Alexa Fluor 647 did not show any fluorescence (data not shown). 
Nuclear localization is a key step that precedes apoptosis induced by Apoptin.[31] As shown in 
Fig. 3B & C, confocal microscopy indicates that MBP-Apoptin may translocate to the nucleus 
following successful PP-75-mediated endosomal release. Comparatively, Fig. 3C, 
corresponding to 5 hours further incubation, seems to have more punctate staining. Given 
MBP-Apoptin’s proclivity to form large aggregates, comprised of 30 – 40 monomers, the red 
punctate staining may simply be MBP-Apoptin aggregation.[29] Also, there are reports that 
MBP-Apoptin forms higher-order complexes with DNA [28] and this aggregation may increase 
with time. Although the extent of nuclear localization has not been determined, evidence of its 
possibility represents an exciting step towards the delivery of functional MBP-Apoptin. 
 The work presented here lays the basis for a novel protein delivery system using the 
pH-responsive polymer PP-75. It describes the first known successful cytoplasmic delivery of 
MBP-Apoptin using a synthetic polymer drug delivery system. The efficient cytoplasmic 
release represents a promising first step in the implementation of Apoptin as a viable anti-
tumour therapeutic. Preliminary research has been conducted to confirm functional activity of 
MBP-Apoptin delivered by PP-75. After treatment of Saos-2 cells with 33 μg mL-1 MBP-
Apoptin and 100 μg mL-1 PP-75 for 3 hours followed by 24 hours further incubation, flow 
cytometry analysis suggested an approximately 30% increase in the population of cells found 
in the mid-apoptotic state, as compared to either MBP-Apoptin or PP-75 alone (data not 
shown). The mid-apoptotic state is characterized by lower DNA content (hypodiploid) and 
presence of fragmented DNA, which is a key feature of apoptosis. Further studies are 
underway to enhance functional activity of apoptosis-inducing MBP-Apoptin mediated by 
PP-75. 
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Experimental 
Protein Preparation: Cloning, expression, and purification of the MBP-Apoptin fusion 
protein has been described previously [29]. Briefly, the Apoptin open reading frame (ORF) 
was cloned into a pMalTB plasmid, which codes for MBP. A coding sequence was inserted to 
link the C-terminal end of MBP and N-terminus of Apoptin with aspartate residues and a 
thrombin consensus site [29]. E. coli BL21 cells were transformed with the plasmid construct 
and the expressed MBP-Apoptin was purified by double passage over an amylose column and 
eluted with 10 mM maltose. The eluate was loaded to an analytical cation exchanged column, 
washed, eluted with a linear gradient of NaCl and protein-containing fractions were dialyzed 
against phosphate buffered saline (PBS) and concentrated to 40 mg mL-1. Fluorescent MBP-
Apoptin was prepared by conjugating Alexa Fluor 647 (AF647) according to manufacturer’s 
instructions (Molecular Probes). Free AF647 was separated from labelled protein by a Bio-
Rad BioGel P-30 Fine size exclusion purification resin. 
Polymer Synthesis and Characterization: L-phenylalanine was grafted onto pendant 
carboxylic acid moieties along the backbone of poly(L-lysine iso-phthalamide) to yield PP-75 
with a 75% stoichiometric molar addition [21]. In summary, poly(L-lysine iso-phthalamide) 
was prepared by polymerization of aqueous L-lysine methyl ester dihydrochloride with an 
equivalent amount of iso-phthaloyl chloride in acetone and subsequent hydrolysis in dimethyl 
sulfoxide (DMSO) with ethanolic sodium hydroxide [13–15]. PP-75 was prepared from the 
coupling reaction for 60 hours between poly(L-lysine iso-phthalamide) and L-phenylalanine 
methyl ester hydrochloride/triethylamine (1/2.4, mol/mol) in an anhydrous DMSO/N,N’-
dimethylformamide (DMF) binary solvent system by N,N’-dicyclohexylcarbodiimide 
(DCC)/4-dimethylaminopyridine (DMAP) mediated amide coupling chemistry [32,33], 
followed by hydrolysis of the resulting polymer with ethanolic sodium hydroxide. The 
solution was precipitated rapidly into five volumes of diethyl ether. The precipitate was 
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collected and redissolved in deionized water. Inorganic salts and residual organic solvents 
were removed by dialysis against deionized water. The solution was concentrated, titrated to 
pH 7.4 and then lyophilized to a fine white powder [21]. The structures of poly(L-lysine iso-
phthalamide) and the grafted PP-75 polymer were confirmed using a Nicolet Nexus FTIR 
spectrometer (Thermo Fisher Scientific, USA) and a Bruker Advance 500 MHz NMR 
spectrometer (Bruker Biospin GmbH, Germany). The molecular weight of poly(L-lysine iso-
phthalamide) (Mw = 35.7 kDa, Mn = 17.9 kDa, polydispersity = 1.99) was determined using 
an aqueous gel permeation chromatography (GPC) system (Viscotek, UK), which was 
calibrated with polyethylene glycol standards. The degree of grafting of PP-75 was measured 
from its 1H NMR spectrum, and used to calculate its molecular weight (degree of grafting = 
63.2%, Mn = 24.9 kDa). The FITC labeled polymer, PP-75-FITC (1.0 mol% FITC), was 
prepared by coupling FITC–NH–(CH2)2–NH2, an amino derivative of FITC from the reaction 
with ethylene diamine using dibutyltin dilaurate as a catalyst, to the carboxylic acid groups of 
PP-75 using standard DCC/DMAP mediated coupling techniques. PP-75-FITC was purified 
by dialysis against deionized water and then lyophilized. A low level of labeling was selected 
here to avoid significant modulation of the polymer properties and fluorescence quenching 
[20–22]. 
 
Acknowledgements 
Rongjun Chen and William Liechty thank the Gates Cambridge Trust and the Universities 
UK organizations for financial support that enabled this work to be carried out. 
 
Received: ((will be filled in by the editorial staff)) 
Revised: ((will be filled in by the editorial staff)) 
Published online: ((will be filled in by the editorial staff)) 
 
  [1]  P. S. Stayton, A. S. Hoffman, N. Murthy, C. Lackey, C. Cheung, P. Tan, L. A. Klumb, 
A. Chilkoti, F. S. Wilbur, O. W. Press, J. Control. Release 2000, 65, 203. 
 9 
   Submitted to  
  [2]  A. F. Olea, J. K. Thomas, Macromolecules 1989, 22, 1165. 
  [3] M. A. Yessine, M. Lafleur, C. Meier, H. U. Petereit, J. C. Leroux, Biochim Biophys 
Acta – Biomembranes 2003, 1613, 28. 
  [4]  J. L. Thomas, S. W. Barton, D. A. Tirrell, Biophys. J. 1994, 67, 1101. 
  [5]  D. A. Tirrell, D. Y. Takigawa, K. Seki, Ann. NY Acad. Sci. 1985, 446, 237. 
  [6]  S. R. Tonge, B. J. Tighe, Adv. Drug Deliv. Rev. 2001, 53, 109. 
  [7]   M. A. Yessine, J. C. Leroux, Adv. Drug Deliv. Rev. 2004, 56, 999. 
  [8]  J. L. Thomas, H. You, D. A. Tirrell, J. Am. Chem. Soc. 1995, 117, 2949. 
  [9] N. Murthy, J. R. Robichaud, D. A. Tirrell, P. S. Stayton, A. S. Hoffman, J. Control. 
Release 1999, 61, 137. 
  [10]  N. Murthy, I. Chang, P. Stayton, A. Hoffman, Macromol. Symp. 2001, 172, 49. 
  [11]  R. A. Jones, C. Y. Cheung, F. E. Black, J. K. Zia, P. S. Stayton, A. S. Hoffman, M. R. 
Wilson, Biochem. J. 2003, 372, 65. 
  [12]  C. Kusonwiriyawong, P. van de Wetering, J. A. Hubbell, H. P. Merkle, E. Walter, Eur. 
J. Pharm. Biopharm. 2003, 56, 237. 
  [13]  M. E. Eccleston, N. K. H. Slater, B. J. Tighe, React. Funct. Polym. 1999, 42, 147. 
  [14]  M. E. Eccleston, M. Kuiper, F. M. Gilchrist, N. K. H. Slater, J. Control. Release 2000, 
69, 297. 
  [15]  M. E. Eccleston, N. K. H. Slater, Patent publication numbers WO2004052402, 
EP1567194 (A1), US2006172418 (A1) and AU2003290222 (A1), 2004. 
  [16]  M. E. Eccleston, C. F. Kaminski, N. K. H. Slater, M. S. J. Briggs, Polymer 2004, 45, 
25. 
  [17]  Z. Yue, M. E. Eccleston, N. K. H. Slater, Polymer 2005, 46, 2497. 
  [18]  X. Dai, M. E. Eccleston, Z. Yue, N. K. H. Slater, C. F. Kaminski, Polymer 2006, 47, 
2689. 
 10 
   Submitted to  
  [19]  R. Chen, Z. Yue, M. E. Eccleston, S. Williams, N. K. H. Slater, J. Control. Release 
2005, 108, 63. 
  [20]  R. Chen., Z. Yue, M. E. Eccleston, N. K. H. Slater, Biomaterials 2008, 29, 4333. 
  [21]  R. Chen, M. E. Eccleston, Z. Yue, N. K. H. Slater, J. Mater. Chem. 2009, 
DOI:10.1039/b902822f. 
  [22] R. Chen, S. Khormaee, M. E. Eccleston, N. K. H. Slater, Biomaterials 2009, 30, 1954. 
  [23]  R. Chen, Ph.D. Thesis, University of Cambridge, UK 2007. 
  [24]   C. Backendorf, A. Visser, A. de Boer, R. Zimmerman, M. Visser, P. Voskamp, Y. H. 
Zhang, M. Noteborn, Ann. Rev. Pharmacol. Toxicol. 2008, 48, 143. 
  [25]   A. A. A. M. Danen-van Oorschot, D. F. Fischer, J. M. Grimbergen, B. Klein, S. M. 
Zhuang, J. H. F.  Falkenburg, C. Backendorf, P. H. A. Quax, A. J. Van der Eb, M. H. M. 
Noteborn, Proc. Natl. Acad. U.S.A. 1997, 94, 5843. 
  [26]  Y.H. Zhang, S. Leliveld, K. Kooistra, C. Molenaar, J. L. Rohn, H. J. Tanke J. P. 
Abrahams, M. H. Noteborn, Exp  Cell Res. 2003, 289, 36. 
  [27]   J. Fogh, J. M. Fogh, T. Orfeo, J. Natl. Cancer Inst. 1977, 59, 221. 
  [28]   S. R. Leliveld, R. T. Dame, M. A. Mommaas, H. K. Koerten, C. Wyman, A. A. A. M. 
Danen-van Oorschot, J. L. Rohn, M. H. M. Noteborn, J. P. Abrahams, Nucl. Acids Res. 2003, 
31, 4805. 
  [29] S. Leliveld, Y. H. Zhang, J. Rohn, M. Noteborn, J. Abrahams, J. Biol. Chem. 2003, 
278, 9042. 
  [30]   C. Lackey, O. Press, A. Hoffman, P. Stayton, Bioconj. Chem. 2002, 13, 996. 
  [31]   A. A. A. M. Danen-van Oorschot, Y. H. Zhang, S. R. Leliveld, J. L. Rohn, M. C. M. J. 
Seelen, M. W. Bolk, A. van Zon, S. J. Erkeland, J. P. Abrahams, D. Mumberg, M. H. M. 
Noteborn, J.  Biol. Chem. 2003, 278, 27729. 
  [32]   E. Haslam, Tetrahedron 1980, 36, 2409. 
 11 
   Submitted to  
  [33]   Y. Okada, Curr. Org. Chem. 2001, 5, 1. 
 
 
Figure 1. Native PAGE analysis of putative PP-75•MBP-Apoptin association. Polymer and 
protein were allowed to equilibrate 3 hours before running.  Long arrow shows MBP-Apoptin 
band. A) High PP-75 concentration: MBP-Apoptin only (33 μg mL-1, 0.6 μM), 700 – 1000 μg 
mL-1 PP-75 with and without MBP-Apoptin. B) Low PP-75 concentration: MBP-Apoptin 
only, 10 – 100 μg mL-1 PP-75 with and without MBP-Apoptin.  
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Figure 2. Influence of PP-75-FITC on uptake of MA-AF647 (33 μg mL-1, 0.6 μM) by Saos-2 
cells. Samples were treated with protein and/or polymer for 1 hour and tested after 1 hour 
further incubation. Error bars represent the standard deviation of three samples. A) and C) 
Proportion of MA-AF647+ viable cells. B) and D) Mean Alexa Fluor 647 fluorescence of 
viable cell population. Viable cells were gated based on propidium iodide exclusion. 
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PP-75-FITC MA-AF647 Overlay 
A 
B 
C 
Figure 3. Intracellular distribution and co-localization of PP-75-FITC and MA-AF647 in 
Saos-2 cells. Cells were treated with PP-75-FITC and/or MA-AF647 for 1 hour and imaged 
after further incubation. Fluorescence images collected from photomultiplier tube (PMT) 1 
are labeled FITC, fluorescence images collected from PMT2 are labeled MA-AF647 and 
overlay images show FITC and MA-AF647 merged with bright field. A) Cells treated with 
100 μg mL-1 PP-75-FITC at 1 hour further incubation. Scale bar equals 50 μm. B) 100 μg mL-
1 PP-75 and 33 μg mL-1 MA-AF647 at 1 hour further incubation. Scale bar equals 25 μm. C) 
100 μg mL-1 PP-75 and 33 μg mL-1 MA-AF647 at 5 hours further incubation showing nuclear 
localization of MBP-Apoptin. 
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